Alder Matthias

CIK 00013708203 companiesBETHESDA, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001370820

Recent Transactions

50 trades

Exercise/Conversion
Gain Therapeutics, Inc.$GANX
Restricted Stock Units
2024-03-26−18,750→ 56,250 total
Exercise/Conversion
Gain Therapeutics, Inc.$GANX
Common Stock
2024-03-26+18,750→ 25,763 total
Exercise/Conversion
Gain Therapeutics, Inc.$GANX
Common Stock
2024-03-26+825→ 26,588 total
Exercise/Conversion
Gain Therapeutics, Inc.$GANX
Common Stock
2024-03-26+637→ 27,225 total
Tax Payment
Gain Therapeutics, Inc.$GANX
Common Stock
2024-03-26$4.06/sh−6,085→ 21,140 total
Exercise/Conversion
Gain Therapeutics, Inc.$GANX
Restricted Stock Units
2024-03-26−825→ 8,250 total
Exercise/Conversion
Gain Therapeutics, Inc.$GANX
Restricted Stock Units
2024-03-26−637→ 6,376 total
Award
Gain Therapeutics, Inc.$GANX
Employee Stock Option (right to buy)
2024-03-21+370,000→ 370,000 total
Sale
Gain Therapeutics, Inc.$GANX
Common Stock
2023-12-21$2.46/sh−206→ 5,286 total
Exercise/Conversion
Gain Therapeutics, Inc.$GANX
Restricted Stock Units
2023-12-20−637→ 7,013 total
Exercise/Conversion
Gain Therapeutics, Inc.$GANX
Common Stock
2023-12-20+637→ 5,492 total
Sale
Gain Therapeutics, Inc.$GANX
Common Stock
2023-12-07$2.50/sh−1,820→ 4,855 total
Exercise/Conversion
Gain Therapeutics, Inc.$GANX
Restricted Stock Units
2023-10-01−825→ 9,075 total
Exercise/Conversion
Gain Therapeutics, Inc.$GANX
Common Stock
2023-10-01+825→ 6,675 total
Exercise/Conversion
Gain Therapeutics, Inc.$GANX
Common Stock
2023-09-20+2,550→ 5,850 total
Exercise/Conversion
Gain Therapeutics, Inc.$GANX
Restricted Stock Units
2023-09-20−2,550→ 7,650 total
Exercise/Conversion
Gain Therapeutics, Inc.$GANX
Restricted Stock Units
2023-07-01−3,300→ 9,900 total
Exercise/Conversion
Gain Therapeutics, Inc.$GANX
Common Stock
2023-07-01+3,300→ 3,300 total
Award
Gain Therapeutics, Inc.$GANX
Employee Stock Option (right to buy)
2023-03-23+150,000→ 150,000 total
Award
Gain Therapeutics, Inc.$GANX
Restricted Stock Units
2023-03-23+75,000→ 75,000 total
Award
Gain Therapeutics, Inc.$GANX
Restricted Stock Units
2022-09-20+10,200→ 10,200 total
Award
Gain Therapeutics, Inc.$GANX
Employee Stock Option (right to buy)
2022-09-20+60,900→ 60,900 total
Award
Gain Therapeutics, Inc.$GANX
Restricted Stock Units
2022-07-15+13,200→ 13,200 total
Award
Gain Therapeutics, Inc.$GANX
Employee Stock Option (right to buy)
2022-07-15+79,200→ 79,200 total
Award
Gain Therapeutics, Inc.$GANX
Non Qualified Stock Option (right to buy)
2021-12-23$5.86/sh+200,000→ 200,000 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2017-06-30$8.93/sh+673→ 4,763 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2017-03-31$9.35/sh+641→ 4,224 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2017-03-06+63,000→ 325,500 total
Award
Sucampo Pharmaceuticals, Inc.
Common stock
2017-03-06+33,000→ 33,000 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2016-12-31$10.46/sh+134→ 3,583 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2016-11-28−24,975→ 262,500 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A
2016-11-28$8.33/sh+24,975→ 28,424 total
Sale
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A
2016-11-28$16.73/sh−24,975→ 3,449 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A
2016-11-25$8.33/sh+99,025→ 102,474 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2016-11-25−99,025→ 287,475 total
Sale
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A
2016-11-25$15.88/sh−99,025→ 3,449 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A
2016-11-23$8.33/sh+26,000→ 29,449 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2016-11-23−26,000→ 386,500 total
Sale
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A
2016-11-23$15.77/sh−26,000→ 3,449 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2016-09-30$9.38/sh+639→ 3,449 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2016-06-30$9.32/sh+752→ 2,810 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2016-03-31$9.29/sh+645→ 2,058 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2016-03-02+62,500→ 412,500 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2015-12-31$14.70/sh+477→ 1,413 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2015-09-30$14.52/sh+413→ 936 total
Award
Sucampo Pharmaceuticals, Inc.
Common Stock, Class A (ESPP)
2015-06-30$13.37/sh+523→ 523 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2015-03-04+50,000→ 350,000 total
Disposition to Issuer
MICROMET, INC.
Stock Option (right to buy)
2012-03-07$9.25/sh−8,334→ 0 total
Disposition to Issuer
MICROMET, INC.
Stock Option (right to buy)
2012-03-07$9.25/sh−66,666→ 0 total
Disposition to Issuer
MICROMET, INC.
Stock Option (right to buy)
2012-03-07$7.84/sh−59,375→ 0 total

Companies

Recent Filings

Address

C/O MICROMET, INC. 6707 DEMOCRACY BLVD., STE. 505

BETHESDA, MD, 28017

View on SEC.gov